Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1984-01-23
1985-04-30
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
A61K 3152, A61K 3170
Patent
active
045144052
ABSTRACT:
Adenosine derivatives of formula I ##STR1## wherein R is H, F, Cl, Br or CF.sub.3, and their physiologically acceptable acid addition salts, are valuable anticonvulsants.
REFERENCES:
patent: 2881164 (1959-05-01), Kissman et al.
patent: 3506643 (1970-04-01), Thiel et al.
Skolnick, Federation Proceedings, vol. 39, Oct. 1980, pp. 3050-3055.
P. Skolnick et al., European Jour. Pharm., 67, (1980), pp. 179-186.
P. Skolnick et al., Life Science, vol. 23, pp. 1473-1480.
P. Skolnick et al., Pharmacology Biochemistry & Behavior, vol. 12, pp. 685-689.
Irmscher Klaus
Uhl Jurgen
Friedman Stanley J.
Merck Patent Gesellschaft mit beschrankter Haftung
LandOfFree
Use of adenosine derivatives as anticonvulsants does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of adenosine derivatives as anticonvulsants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of adenosine derivatives as anticonvulsants will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1967921